QA: Northwest Biotherapeutics INC in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001072379_2019_Northwest_Biotherapeutics_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001072379, Northwest Biotherapeutics INC

  xvar xval
0 AssetsCurrent 23,798,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 108,000
3 remainder_Assets 761,000
4 LiabilitiesCurrent 69,840,000
5 LiabilitiesNoncurrent 1,986,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 20,339,851
9 ResearchAndDevelopmentExpense 5,494,298
10 remainder_Expenses 9,558,959
11 remainder_Revenues 422,154
12 remainder_NetIncome 680,667
13 remainder_ComprehensiveNetIncome -2,439,714
  yvar yval
0 Assets 24,667,000
1 Liabilities 71,826,000
2 Expenses 35,393,108
3 Revenues 422,154
4 StockholdersEquity -47,159,000
5 NetIncome -34,290,287
6 ComprehensiveNetIncome -35,510,144
7 BaseVar 67,714,322
8 EconomicCapitalRatiobeforeLimitedLiability -2.87
9 EconomicCapitalRatio 0.731

Edgar->Model Mapping

Feature Distribution

Change over Time